Latest filing published 26 Feb 2018 for Breathtec BioMedical, Inc., €8,014.
This profile gathers the share dealings of Michael Sadhra in Breathtec BioMedical, Inc. Over a trading history stretching from 25 November 2016 to 22 February 2018, the count stands at 4 filings.
Market trades split into 1 purchase (€8,014) and 2 sales (€65k). Taken together, the sales exceed the purchases by €57k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2018 alone, the filings show 1 purchase and 2 sales.
On 26 February 2018 came the latest disclosure, an open-market purchase for €8,014 in Breathtec BioMedical, Inc. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations